Several new contraceptives have become available to women in recent years. These new agents include ultra-low-dose oral contraceptives as well as injectable, vaginal, and patch formulations. We review these, with emphasis on the Yasmin pill (which contains a new progestin), the Lunelle once-a-month injection, the Ortho Evra patch, the NuvaRing vaginal ring, the Mirena intrauterine device, and emergency contraceptive kits. Patient education regarding these options is essential for patient compliance and satisfaction.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3949/ccjm.70.8.681 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!